Cipla Share Price Target : Although there are lakhs of shares listed in the stock market, today we are going to tell you about such a stock which can go up a lot in the coming time. This article will provide more details about Cipla Share Price Target 2025, 2026 to 2030.
Contents
Today’s blog is Cipla Share Price Target And Prediction 2025-30 : Fundamental & Financial Analysis, by reading which you can take your investment decision. Read the Cipla Share Target Price 2025-30 blog carefully so that you do not miss any information…
Cipla : Introduction
Cipla Limited is an India-based company, primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment is engaged in the development, manufacturing, sale, and distribution of generic or branded generic medicines, as well as active pharmaceutical ingredients (APIs).
The New Ventures segment comprises the Company’s operations, consumer healthcare, biosimilars, and specialty businesses. The Company’s product portfolio includes complex generics, as well as respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system (CNS) drugs.
The Company’s geographic segments include India, the United States, South Africa, and the rest of the world. The Company has a network of manufacturing, trading, and other incidental operations in India and international markets. The Company has approximately 47 manufacturing sites.
Cipla Historical Share Price Performance
Understanding Cipla past performance can provide context for future expectations…
| Month | Approx Avg Open (₹) | Approx Avg Close (₹) | Trend & Key Note |
|---|---|---|---|
| Jan 2025 | ~₹1,460 | ~₹1,479 | Early-year strength post‑year-end |
| Feb 2025 | ~₹1,480 | ~₹1,408 | Mid‑month dip before recovery |
| Mar 2025 | ~₹1,445 | ~₹1,523 | Strong rebound into quarterly earnings |
| Apr 2025 | ~₹1,525 | ~₹1,463 | Volatility post‑earnings release |
| May 2025 | ~₹1,485 | ~₹1,466 | Range‑bound consolidation around mid‑₹1,480 |
| Jun 2025 | ~₹1,510 | ~₹1,503 | Mild correction after peak |
| Jul 2025 | ~₹1,491 | ~₹1,532 | Reversal rally towards ₹1,530 by month-end |
Cipla Share Price Target And Prediction 2025-30
Now let’s take a look at Cipla Share Price Target And Prediction 2025-30…
| YEAR | TARGET |
| 2025 | 1,662 |
| 2026 | 1,930 |
| 2027 | 2,240 |
| 2028 | 2,600 |
| 2029 | 3,017 |
| 2030 | 3,502 |
- Read : Ashok Leyland Share Price Target And Forecast 2025-30 : Complete Guide
- Read : Bajaj Auto Share Price Target And Forecast 2025–30 : Complete Guide For You
Cipla Share Price Targets by Brokerage Firms
Several brokerage firms have provided their insights and Cipla share target price…
| Brokerage Firm | Rating | Target Price (₹) | Upside from ₹1,532 | Commentary |
|---|---|---|---|---|
| Nomura India | Buy | ₹1,780 | +16% | Based on USFDA gAbraxane launch & chronic therapy leadership (Business Today) |
| Antique Securities | Buy | ₹1,875 | +22% | Cites strong PAT growth & complex generics pipeline (The Economic Times, The Economic Times) |
| Investec | Buy | ₹1,800 | +18% | Confident on lanreotide supply and India Q1 momentum (Stock Markets) |
| Motilal Oswal | Buy | ₹1,600 | +4% | Based on chronic therapy and US asset uptick (Stock Markets) |
| Nuvama / Choice Broking* | Hold/Add | ₹1,620–1,651 | +6–8% | Mixed near-term sentiment post-results (The Economic Times) |
Cipla Share Price Target : Fundamental Analysis
Now let’s take a look at the company’s fundamentals to get more details on Cipla Share price target…
| Fundamental | Data |
| Market Cap | 1,23,675 Cr. |
| P/E Ratio | 22.93% |
| P/B Ratio | 3.96% |
| Industry P/E | 35.62% |
| Debt To Equity | 0.01% |
| ROE | 16.90% |
| EPS (TTM) | 66.76 |
| Div. Yield | 1.04% |
| Book Value | 386.18 |
| Face Value | 2 |
Cipla Share Price Target : Financial Performance
Now to know Cipla Target Price in more detail, we take a look at the financial position of the company for the last 5 years and this data is according to Groww.in…
Company Revenue
| Year | Revenue (In Crore) |
| 2021 | 19,426 |
| 2022 | 22,044 |
| 2023 | 23,229 |
| 2024 | 26,521 |
| 2025 | 28,406 |
Company Profit
| Year | Profit (In Crore) |
| 2021 | 2,401 |
| 2022 | 2,559 |
| 2023 | 2,835 |
| 2024 | 4,155 |
| 2025 | 5.291 |
Company Net Worth
| Year | Net Worth (In Crore) |
| 2021 | 18,586 |
| 2022 | 21,117 |
| 2023 | 23,714 |
| 2024 | 26,802 |
| 2025 | 31,289 |
Cipla Share Price Target : Shareholding Pattern
Now let’s take a look at the company’s Shareholding Pattern to get more details on Cipla Share Target Price…
| Quarter | Dec 24 | Mar 25 | Jun 25 |
| Promoters | 29.19% | 29.20% | 29.19% |
| Foreign Institutions | 26.65% | 26.28% | 25.24% |
| Retails And Other | 16.44% | 16.37% | 16.31% |
| Mutual Funds | 20.46% | 20.51% | 20.44% |
| Other Domestic Institutions | 7.25% | 7.64% | 8.81% |
Cipla Target Share Price : Strengths And Limitations
Now let’s take a look at the company’s Strengths And Limitations to get more details on Cipla target share price and this data is according to Ticker.finology.in…
| Strengths | Limitations |
| The company has shown a good profit growth of 22.02% for the Past 3 years. | The company has shown a poor revenue growth of 13.61% for the Past 3 years. |
| Company is virtually debt free. | |
| Company has a healthy Interest coverage ratio of 245.29. | |
| The Company has been maintaining an effective average operating margins of 23.13% in the last 5 years. | |
| Company’s PEG ratio is 0.35. | |
| The company has an efficient Cash Conversion Cycle of -29.63 days. | |
| Company has a healthy liquidity position with current ratio of 5.19. | |
| The company has a good cash flow management; CFO/PAT stands at 1.15. |
Cipla Target Share Price : Investment Considerations
Now take a look at Investment Considerations factors of Cipla Share Price Target 2025…
Chronic Portfolio
Cipla holds leadership in inhalation therapies (e.g. Albuterol) and oncology (Lanreotide), generating performance in both domestic and U.S. markets.
Increasing R&D Focus
It files ANDAs for drugs like Gattex (Teduglutide), while launching biosimilar and specialty assets—future growth drivers.
Global Diversification
Nearly 40% of revenue originates from international markets (e.g., U.S., South Africa), helping manage domestic volatility and currency moves.
Strong Financial Metrics
Q1FY26 PAT surged ~50% YoY; EBITDA margin ~28%, net profit growth outpaces revenue growth—signalling operating leverage.
Resilient Business
As a diversified sub-sector, pharma stocks often serve as a defensive hedge during macro volatility; Cipla’s leadership in affordable generics strengthens this positioning.
Cipla Share Target Price : Factors Influencing
Now take a look at Cipla Target Share Price, many factors affect it…
Strong Domestic And Global Sales
Cipla’s revenue from India and international markets including the US and Europe significantly impacts its stock price.
Expansion Into Specialty Drugs
Cipla’s focus on specialty products in oncology, respiratory care and biosimilars offers substantial growth opportunities.
Regulatory Approvals
Approvals from global regulatory bodies such as the US FDA and EMA boost investor confidence and stock growth.
Product Launches
New product launches, especially in high-demand therapeutic areas, contribute to revenue and stock valuation.
Research And Development
Cipla’s investments in R&D for generics and innovative therapies enhance its competitiveness in the market.
Global Health Trends
Demand for affordable drugs, especially in respiratory care and critical care areas, plays a key role in the company’s performance.
Cipla Share Price Target : Conclusion
Based on the Cipla Share Price Target And Prediction 2025-30 : Fundamental & Financial Analysis blog, it can be said that Cipla Limited is a trusted name in the pharmaceutical industry, with a strong track record of growth and innovation. With its leadership in the respiratory, anti-infective and specialty segments, Cipla remains an attractive option for those investing in the healthcare sector.
Based on Cipla Share Price Target blog the company has shown a good profit growth of 22.02% in the last 3 years. The company is virtually debt free.
- Read : Bharat Electronics Share Price Target And Forecast 2025–30 : A Detailed Analysis
- Read : REC Limited Share Price Target And Forecast 2025–30 : A Detailed Analysis
- Read : CRISIL Share Price Target And Forecast 2025–30 : Fundamental & Financial Analysis
Disclaimer : We are Not SEBI Registered and this article is for informational purposes only. The views and recommendations expressed above are those of individual analysts and not FactBeez. We advise investors to check with certified experts before making any investment decision which will help you make informed decisions and reduce the chances of losses.
FAQs About Cipla Share Price Target
What is the Cipla share price target tomorrow
The Cipla share price target tomorrow Is Rs. 1,463-1,500
What is the price target for Cipla in 2025
The price target for Cipla in 2025 Is Rs. 1,662
What is the Cipla share price target 2027
The Cipla share price target 2027 Is Rs. 2,240
What is the Cipla share price target 2030
The Cipla share price target 2030 Is Rs. 3,502
What is the Cipla share price target 2040
The Cipla share price target 2040 Is Rs. 5,812
